UK markets closed
NIKKEI 225
38,073.98 -128.39 (-0.34%) HANG SENG
18,537.81 +223.95 (+1.22%) CRUDE OIL
79.24 +0.25 (+0.32%) GOLD FUTURES
2,338.50 +16.20 (+0.70%) DOW
39,301.62 +245.23 (+0.63%) Bitcoin GBP
49,526.41 -417.59 (-0.84%)
Celadon Pharmaceuticals Plc (CEL.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
At close: 05:08PM BST
| Previous close | 101.50 |
| Open | 105.00 |
| Bid | 98.00 x N/A |
| Ask | 105.00 x N/A |
| Day's range | 98.00 - 105.00 |
| 52-week range | 73.44 - 180.00 |
| Volume | |
| Avg. volume | 47,408 |
| Market cap | 65.172M |
| Beta (5Y monthly) | -0.02 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.13 |
| Earnings date | 03 Jun 2024 - 07 Jun 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 235.00 |
Simply Wall St.Celadon Pharmaceuticals First Half 2023 Earnings: UK£0.07 loss per share (vs UK£0.25 loss in 1H 2022)
Celadon Pharmaceuticals ( LON:CEL ) First Half 2023 Results Key Financial Results Net loss: UK£4.30m (loss narrowed by...
- Simply Wall St.
Owning 61% in Celadon Pharmaceuticals Plc (LON:CEL) means that insiders are heavily invested in the company's future
Key Insights Significant insider control over Celadon Pharmaceuticals implies vested interests in company growth A...
© 2024 Yahoo. All rights reserved.